Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model
Author:
Affiliation:
1. Citoxlab, Laval, Canada
2. Partner Therapeutics, Inc, Boston, MA, USA
Funder
Biomedical Advanced Research and Development Authority
Publisher
Informa UK Limited
Subject
Radiology, Nuclear Medicine and imaging,Radiological and Ultrasound Technology
Link
https://www.tandfonline.com/doi/pdf/10.1080/09553002.2019.1673499
Reference49 articles.
1. Stenotrophomonas maltophilia as an Emerging Ubiquitous Pathogen: Looking Beyond Contemporary Antibiotic Therapy
2. Amgen Inc. 2018. Neupogen (filgrastim) – US prescribing information. [accessed 2019 Oct 2]. https://www.pi.amgen.com/∼/media/amgen/repositorysites/pi-amgen-com/neupogen/neupogen_pi_hcp_english.pdf
3. Amgen Inc. 2019. Neulasta (pegfilgrastim) – US prescribing information. [accessed 2019 Oct 2]. https://www.pi.amgen.com/∼/media/amgen/repositorysites/pi-amgen-com/neulasta/neulasta_pi_hcp_english.pdf
4. Evaluation of role of G-CSF in the production, survival, and release of neutrophils from bone marrow into circulation
5. Acute Gastrointestinal Syndrome in High-Dose Irradiated Mice
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. BIO 300: A Prophylactic Radiation Countermeasure for Acute Radiation Syndrome;Military Medicine;2024-08-19
2. BIO 300 Attenuates Whole Blood Transcriptome Changes in Mice Exposed to Total-Body Radiation;International Journal of Molecular Sciences;2024-08-13
3. Pathology of acute sub-lethal or near-lethal irradiation of nonhuman primates prophylaxed with the nutraceutical, gamma tocotrienol;Scientific Reports;2024-06-10
4. Pharmacokinetic and Metabolomic Studies with a Promising Radiation Countermeasure, BBT-059 (PEGylated interleukin-11), in Rhesus Nonhuman Primates;Radiation Research;2024-05-08
5. Histopathological studies of nonhuman primates exposed to supralethal doses of total- or partial-body radiation: influence of a medical countermeasure, gamma-tocotrienol;Scientific Reports;2024-03-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3